Newstral
Article
The Globe and Mail on 2017-12-13 13:55
Aurora Cannabis wins rights for licensing talks with CannaRoyalty
Related news
- Aurora Cannabis reportedly wins support for CanniMed Therapeutics takeoverThe Globe and Mail
- MAurora Cannabis exec Cam Battley steps downmarketwatch.com
- ‘Nobody got any sleep last night’: Aurora Cannabis lands CanniMed for $1.1 billion after marathon talksbusiness.financialpost.com
- Aurora Cannabis Stock: Why This Weed Play Could Easily Doubleprofitconfidential.com
- ACB Stock: Aurora Cannabis Inc Climbs Following Revenue Guidanceprofitconfidential.com
- MAurora Cannabis earnings tops $100 million, revenue nearly quadruplesmarketwatch.com
- Shares surge as Aurora Cannabis posts record November revenueThe Globe and Mail
- Aurora Cannabis Stock Impresses with Q3 Financial Reportprofitconfidential.com
- Aurora Cannabis Stock Technical Analysis: A Correction Is Imminentprofitconfidential.com
- IAurora Cannabis is trading down after reporting its Q1 resultsinvezz.com
- IAurora Cannabis shares are trading lower after-hours: here’s whyinvezz.com
- Aurora Cannabis formally launches hostile takeover bid for CanniMedThe Globe and Mail
- Aurora Cannabis vs Canopy Growth Stock: The Better Investment?profitconfidential.com
- MAurora Cannabis raises $345 million through convertible debt offeringmarketwatch.com
- MWhere Aurora sees cannabis opportunity beyond selling buds in Canadamarketwatch.com
- IAurora Cannabis is on track to be EBITDA profitableinvezz.com
- ACB Stock Split: Should Aurora Cannabis Stock Consider a Divide?profitconfidential.com
- IHere’s why Aurora Cannabis lost 9% on Friday morninginvezz.com
- IAurora Cannabis CEO: ‘our transformation plan is on track’invezz.com
- MAurora Cannabis to acquire 51% stake in Portugal's Gaia Pharma, set up medical cannabis facilitymarketwatch.com